via

Swiss drug maker Actelion said on Monday it would not develop its bosentan medicine, sold as Tracleer, as a treatment for metastatic melanoma, a form of skin cancer.

Actelion said in a statement on Monday that preliminary efficacy data generated in the proof-of-concept study evaluating bosentan in metastatic melanoma did not support a full clinical development program.

via reuters.com

Over half of influenza patients in Japan showing abnormal behavior had taken the drug Tamiflu, but it is not clear if there was a causal link between the drug and their actions, a government report showed on Monday.

Japan is investigating whether there is any link between Tamiflu, made by Roche Holding AG, and neuropsychiatric problems after more than 100 people, mostly young, showed erratic behavior such as jumping from buildings after taking the drug.

There have been eight cases of deaths after abnormal or possibly abnormal behavior.

via reuters.com

via

via

via